ICTHIC magazine

24/05/2023

Bleeding risk, cancer, and atrial fibrillation, what do we know?

A connection exists between cancer and atrial fibrillation (AF) as cancer is statistically associated with AF within the first 3 months after a cancer diagnosis.

A diagnosis of AF carries a risk of a cancer diagnosis as well.

Patients with cancer also have an increased risk of developing venous thromboembolism (VTE) and major bleeding, especially when they begin anticoagulation therapy.

While specific scores are available to evaluate VTE risk in cancer patients, the standardized risk models available for AF (CHA2DS2-VASC and HAS-BLED score) do not consider the presence of malignancy.

Keep reading the article here.

👇👇👇

Cancer and atrial fibrillation A connection exists between cancer and atrial fibrillation (AF) as cancer is statistically associated with AF within the first 3 months after cancer diagnosis [1]. A review and metanalysis highlighted that people with newly diagnosed cancer had a significantly increase...

10/03/2023

A new ICTHIC webinar is coming soon!

Challenges in the management of fragile CAT patients (older patient population & palliative care)
15 MAY 2023 – 18:00-19:00 CET

Speakers: Jay Easaw, Simon Noble, Thomas R.J. McFarlane
Annie Young will chair this event.

Check out the agenda 👉👉 https://rb.gy/7ffhu1

The webinar is free to attend, and an application has been made to the UEMS EACCMER® for CME accreditation.

28/11/2022

Check out the next ICTHIC Magazine webinar:

Long-term treatment & DDI implications in the management of CAT
29 November 2022 – 18:00-19:00 CET

Speakers: Luis Jara Palomares, Hans-Peter Lipp, Tzu-Fei Wang
Marc Carrier will chair this event.

👉👉 https://rb.gy/watrjm

The webinar is free to attend, and it has been granted 1 European CME credit (ECMEC®) by the European Accreditation Council for Continuing Medical Education (EACCME®).

01/04/2022

The first ICTHIC podcast is live. Check it out 👇👇👇

Cliona Kirwan, professor in surgical clinical trials at the University of Manchester, talks about thrombosis and coagulation management in breast cancer.

Breast cancer is the most commonly diagnosed cancer in women accounting for a quarter of cancer cases worldwide. This equates to about 2.3 million women being diagnosed in 2020, with incidence rates increasing worldwide. In addition to this, breast cancer survival rates in both early and metastatic....

04/03/2022

What is the use of direct oral anticoagulants in pediatric cancer patients?

Most children with cancer-associated thrombosis are still treated with low-molecular-weight heparin.

Unlike adults, direct oral anticoagulants (DOACs) have not been approved in the pediatric population until recently, when rivaroxaban was approved for pediatric use by the EMA and the FDA.

The phase III Einstein Jr multicenter randomized controlled study (NCT02234843) showed that rivaroxaban is safe and effective in children with VTE.

The DIVERSITY study (NCT01895777), compared the efficacy and safety of dabigatran etexilate to the standard of care in pediatric patients with VTE. The results indicate that dabigatran was non-inferior to the standard of care in terms of efficacy and might be a suitable alternative to care standards. However, in this study, there was not a represented population for cancer patients.

Therefore, the use of DOACs in children will certainly increase in the future, but it will take time since many drugs are not registered yet for pediatric cancer patients.

Read and watch the Prof. Kenet's full interview https://rb.gy/dvlkdf

23/02/2022

📣📣 ALERT: The webinar recording is online!

Watch the talks you may have missed live.
The full webinar recording and the presentations of each speaker are available here 👉 https://rb.gy/suvi5r

Check them out!

P.S. You can re-watch all our webinars. Just go through our webinar section on magazine.icthic.com

14/02/2022

Meet one of the speakers of our next : Florian Scotté

He is vice-president of AFSOS (Association Francophone des Soins Oncologiques de Support), the French-speaking association for supportive care in oncology.

During the next ICTHIC Webinar

"CAT management: challenges in different cancer populations" (February 17, 2022, 18.00 CET)

he will share some updates on AFSOS guidelines.

Check out our webinar program and register here https://rb.gy/2nijhw

10/02/2022

📣 Only 7 days to our next webinar
⏰ Only a few spots left

February 17, 2022, 18.00 CET

"CAT management: challenges in different cancer populations"

Register here: https://rb.gy/2nijhw

Walter Ageno, Florian Scotté, and

Check out the agenda and register today: https://rb.gy/2nijhw

26/01/2022

What is the thrombosis risk in patients with ovarian cancer undergoing neoadjuvant chemotherapy (NACT)?

Ovarian cancer carries a high risk of venous thromboembolism (VTE) events, and chemotherapy is a well-known significant risk factor for VTE.

In two retrospective cohort studies of patients with ovarian cancer receiving NACT, VTE risk during the primary treatment period was 18–27%.

A total of 8–12% were diagnosed with VTE during NACT, 3–6% during the immediate postoperative period following interval debulking, and 3–10% during subsequent adjuvant chemotherapy.

The risk in women undergoing NACT might be higher also because of the higher cancer and/or comorbidity burden that prompts the decision to defer primary surgery.

Keep reading our latest article.

Ovarian cancer is the ninth most common type of cancer and the seventh most common cause of cancer death in women [1]. In 2020, the estimated incidence was 6.6 per 100,000 women and the mortality was 4.2 per 100.000 women worldwide [1]. The median age at diagnosis is 63 years, and the 5-year surviva...

21/01/2022

📣📣A new article is out!📣📣
"Bleeding risk, cancer, and atrial fibrillation."

A connection exists between cancer and atrial fibrillation (AF) as cancer is statistically associated with AF within the first 3 months after a cancer diagnosis.

A diagnosis of AF carries a risk of a cancer diagnosis as well.

Patients with cancer also have an increased risk of developing venous thromboembolism (VTE) and major bleeding, especially when they begin anticoagulation therapy.

While specific scores are available to evaluate VTE risk in cancer patients, the standardized risk models available for AF (CHA2DS2-VASC and HAS-BLED score) do not consider the presence of malignancy.

Keep reading the article here.

👇👇👇

Cancer and atrial fibrillation A connection exists between cancer and atrial fibrillation (AF) as cancer is statistically associated with AF within the first 3 months after cancer diagnosis [1]. A review and metanalysis highlighted that people with newly diagnosed cancer had a significantly increase...

12/01/2022

What information should be given to patients with cancer, and when should it be given on the cancer care pathway?

Patients with cancer are going through a particularly uncertain period.

Together with the uncertainty about their future, they must deal with uncertainty resulting from the COVID-19 pandemic, the risk of infection, and difficulties in everyday treatments and checkups.

Due to the COVID-19 pandemic in Europe:

- An estimated 1 million cancer cases could be undiagnosed

- An estimated 100 million cancer screening tests were not performed, leading to later stage diagnoses and decreased overall survival

- Up to one in two people with potential cancer symptoms were not urgently referred for diagnosis

- One in every five cancer patients is currently still not receiving the surgical or chemotherapy treatment they need.

In addition, COVID-19 and cancer are both risk factors for VTE.

For this reason, in this pandemic period, it is even more important to raise awareness about the risks of VTE in patients with cancer.

But what information should be given to patients with cancer, and when should it be given on the cancer care pathway?

Check out what Prof Annie Young said during the last ICTHIC webinar.

During the ICTHIC webinar “Joint forces: the Patient & the Multi-disciplinary Team working together to improve outcomes in CAT,” Prof Annie Young gave a lecture on the importance of sharing information about cancer-associated thrombosis (CAT) to patients with cancer. Here, we summarize the key m...

10/01/2022

Do you know that 90 min of sitting can reduce blood flow by half?

90 minutes of sitting is enough to reduce blood flow behind your knees. Prolonged sitting can enhance your risk of developing deep vein thrombosis (DVT).

Everyone is at risk of blood clots, but some factors can increase your risk:

- Be Immobile for long periods
- Hospitalization and surgery
- Older age
- Pregnancy
- Cancer
- Trauma
- Overweight

Read more about the DVT risk here https://rb.gy/i7dzxb
And learn how to prevent it 👇

05/01/2022

Save the date May 27-29, 2022

The 11th International Conference on Thrombosis and Hemostasis Issues in Cancer is coming!

If you want to submit an abstract, hurry up; the deadline is January 15th, 2022.

You can find all the information you need here https://rb.gy/cao6er

31/12/2021

A new year is about to start, and ICTHIC Magazine has prepared many surprises for its readers.

Keep following ICTHIC Magazine and subscribe to our newsletter to stay updated with the most recent news.

Visit magazine.icthic.com

Have a lovely 2022 beginning.

28/12/2021

A new article is out!

"An update on the VTE standard set of patient outcomes, ICHOM"

Prof Erik Klok talks about the work of the ICHOM)Working Group for Venous Thromboembolism (VTE).

During the ICTHIC webinar “Joint forces: the Patient & the Multi-disciplinary Team working together to improve outcomes in CAT,” Prof Klok gave a lecture on the work of the International Consortium for Health Outcomes Measures (ICHOM) Working Group for Venous Thromboembolism (VTE) (the ICHOM-VTE...

25/12/2021

𝐇𝐚𝐩𝐩𝐲 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐟𝐫𝐨𝐦 𝐈𝐂𝐓𝐇𝐈𝐂 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞!

22/12/2021

How can we improve CAT awareness and patient outcomes?

Currently, the provision of patient information about the risks, signs, and symptoms of CAT is inadequate.

Patients and clinical staff’s poor knowledge about CAT lead to delayed presentation, diagnosis, and treatment of VTE.
The implementation of a video in clinical practice helped improve CAT awareness among patients and healthcare providers.

Check out our latest article from a lecture by Simon Noble.

During the ICTHIC webinar “Joint forces: the Patient & the Multi-disciplinary Team working together to improve outcomes in CAT,” Prof Noble talked about the EMPOWER study, which evaluated the efficacy of a patient-designed information video on raising patients’ and healthcare providers’ awar...

20/12/2021

Do you know the symptoms of blood clots?

Recognise the signs of a pathology is essential to protect ourselves.

Blood clots can happen in a person’s leg or arm, but also in the lungs. In this last case it is called pulmonary embolism, or PE.

PE can be deadly and sudden death is the first symptom in about 1 over 4 people who have a PE.

One person every three people with blood clots will have a recurrence within 10 years.

This is why it is so important to recognise the symptoms of blood clots.

If you want to know more check here https://rb.gy/nhwyh2